DUBLIN--(BUSINESS WIRE)--The "Global Veterinary Vaccines Market - Segmented by Type, Companion Animal Vaccines, Technology, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global veterinary vaccines market is expected to register a CAGR of 8% during the forecast period 2018 to 2023.
The livestock sector is highly dynamic, globally. In developing countries, it is evolving in response to rapidly increasing demand for livestock products. In developed countries, demand for livestock products is stagnating, while many production systems are increasing their efficiency and environmental sustainability.
The other factors, such as increasing adoption of companion animals, rising incidence of zoonotic diseases, and initiatives by various government agencies, animal associations, and leading players are driving the veterinary vaccines market.
Key Highlights
-
High Storage Costs for Vaccines is Hindering Growth
- United States Lead the Market in North America Region
Developments in the Market
- April 2018: Zoetis to expand Animal Vaccine Research and Manufacturing in Suzhou, China.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
- Bayer
- Boehringer Ingelheim
- Ceva
- Elanco
- Merck Animal Health
- Vetoquinol
- Virbac
- Zoetis Animal Healthcare
For more information about this report visit https://www.researchandmarkets.com/research/v22wmf/veterinary?w=4
